Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The acquisition will enable creation of a fully integrated, enterprise-wide capability to discover, design and develop next-generation immunotherapies at scale by leveraging AI and machine learning technologies across BioNTech’s therapeutic platforms and operations.
Lead Product(s): Undisclosed
Therapeutic Area: Technology Product Name: Undisclosed
Highest Development Status: Discovery PlatformProduct Type: Undisclosed
Partner/Sponsor/Collaborator: BioNTech
Deal Size: $548.6 million Upfront Cash: $548.6 million
Deal Type: Acquisition July 31, 2023
Details:
The acquisition will enable creation of a fully integrated, enterprise-wide capability to discover, design and develop next-generation immunotherapies at scale by leveraging AI and machine learning technologies across BioNTech’s therapeutic platforms and operations.
Lead Product(s): Undisclosed
Therapeutic Area: Technology Product Name: Undisclosed
Highest Development Status: Discovery PlatformProduct Type: Undisclosed
Partner/Sponsor/Collaborator: BioNTech
Deal Size: $688.0 million Upfront Cash: $443.3 million
Deal Type: Acquisition January 10, 2023